PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | cerdulatinib | C20H27N7O3S

cerdulatinib

  • Molecular FormulaC20H27N7O3S
  • Average mass445.539 Da
  • Monoisotopic mass445.189606 Da
  • ChemSpider ID32822046

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1198300-79-6 [RN]
4-(Cyclopropylamino)-2-({4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl}amino)-5-pyrimidincarboxamid [German] [ACD/IUPAC Name]
4-(Cyclopropylamino)-2-({4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl}amino)-5-pyrimidinecarboxamide [ACD/IUPAC Name]
4-(Cyclopropylamino)-2-({4-[4-(éthylsulfonyl)-1-pipérazinyl]phényl}amino)-5-pyrimidinecarboxamide [French] [ACD/IUPAC Name]
5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]- [ACD/Index Name]
9987
cerdulatinib [INN]
cerdulatinib [French] [INN]
cerdulatinib [Spanish] [INN]
cerdulatinibum [Latin] [INN]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      JAK inhibitor; Syk inhibitor TargetMol T2487
    • Bio Activity:

      Cerdulatinib(PRT-062070; PRT2070) is an novel oral dual Syk/JAK inhibitor. MedChem Express
      Cerdulatinib(PRT-062070; PRT2070) is an novel oral dual Syk/JAK inhibitor.; IC50 value:; Target: Syk/JAK inhibitor; Cerdulatinib is currently being studied in patients with genetically-defined hematologic cancers, as well as for patients who have failed therapy due to relapse or acquired mutations. MedChem Express HY-15999
      Cerdulatinib(PRT-062070; PRT2070) is an novel oral dual Syk/JAK inhibitor.;IC50 value:;Target: Syk/JAK inhibitorCerdulatinib is currently being studied in patients with genetically-defined hematologic cancers, as well as for patients who have failed therapy due to relapse or acquired mutations. MedChem Express HY-15999
      JAK MedChem Express HY-15999
      JAK Syk MedChem Express HY-15999
      JAK/STAT Signaling MedChem Express HY-15999
      JAK/STAT Signaling; Angiogenesis TargetMol T2487
      JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; MedChem Express HY-15999
      Syk/JAK TargetMol T2487

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.4±0.1 g/cm3
Boiling Point: 741.9±70.0 °C at 760 mmHg
Vapour Pressure: 0.0±2.5 mmHg at 25°C
Enthalpy of Vaporization: 108.2±3.0 kJ/mol
Flash Point: 402.5±35.7 °C
Index of Refraction: 1.683
Molar Refractivity: 116.9±0.4 cm3
#H bond acceptors: 10
#H bond donors: 4
#Freely Rotating Bonds: 8
#Rule of 5 Violations: 1
ACD/LogP: 0.37
ACD/LogD (pH 5.5): 0.81
ACD/BCF (pH 5.5): 1.83
ACD/KOC (pH 5.5): 38.08
ACD/LogD (pH 7.4): 1.33
ACD/BCF (pH 7.4): 5.97
ACD/KOC (pH 7.4): 123.97
Polar Surface Area: 142 Å2
Polarizability: 46.3±0.5 10-24cm3
Surface Tension: 81.6±5.0 dyne/cm
Molar Volume: 308.3±5.0 cm3

Click to predict properties on the Chemicalize site






Advertisement